You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

Polymyxin b sulfate - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic drug sources for polymyxin b sulfate and what is the scope of freedom to operate?

Polymyxin b sulfate is the generic ingredient in five branded drugs marketed by Glaxosmithkline, Adrastea Pharma, Eugia Pharma, Fresenius Kabi Usa, Gland, Hikma, Rising, Xellia Pharms Aps, X Gen Pharms, Paddock Llc, Allergan, Bausch And Lomb, Epic Pharma Llc, Sandoz, and Somerset Theraps Llc, and is included in fifteen NDAs. Additional information is available in the individual branded drug profile pages.

There are ten drug master file entries for polymyxin b sulfate. Seven suppliers are listed for this compound.

Summary for polymyxin b sulfate
US Patents:0
Tradenames:5
Applicants:15
NDAs:15
Drug Master File Entries: 10
Finished Product Suppliers / Packagers: 7
Raw Ingredient (Bulk) Api Vendors: 11
Clinical Trials: 6
What excipients (inactive ingredients) are in polymyxin b sulfate?polymyxin b sulfate excipients list
DailyMed Link:polymyxin b sulfate at DailyMed
Recent Clinical Trials for polymyxin b sulfate

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Madonna Magdy FahmyEarly Phase 1
University of MiamiN/A
Bascom Palmer Eye InstituteN/A

See all polymyxin b sulfate clinical trials

Pharmacology for polymyxin b sulfate
Medical Subject Heading (MeSH) Categories for polymyxin b sulfate

US Patents and Regulatory Information for polymyxin b sulfate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Paddock Llc POLYMYXIN B SULFATE polymyxin b sulfate POWDER;FOR RX COMPOUNDING 062455-001 Jul 27, 1983 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
X Gen Pharms POLY-RX polymyxin b sulfate POWDER;FOR RX COMPOUNDING 061578-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Hikma POLYMYXIN B SULFATE polymyxin b sulfate INJECTABLE;INJECTION 060716-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Xellia Pharms Aps POLYMYXIN B SULFATE polymyxin b sulfate INJECTABLE;INJECTION 202766-001 Jan 15, 2014 AP RX No Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Adrastea Pharma POLYMYXIN B SULFATE polymyxin b sulfate INJECTABLE;INJECTION 063000-001 Sep 30, 1994 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.